Zdrowie i gospodarka · 14/08/2006

FDA Releases Draft Guidance on Donor Deferral for Creutzfeldt-Jakob Disease Risk Reduction

The FDA has made available a draft document outlining a proposed amendment to its 2002 guidance on reducing the risk of Creutzfeldt-Jakob disease transmission through blood transfusions, specifically recommending donor deferral for those who received a transfusion in France since 1980.